Successful management of a neonate with OTC deficiency presenting with hyperammonemia and severe cardiac dysfunction with extracorporeal membrane oxygenation support and continuous renal replacement therapy.
Adrian Christian MattkeFumiaki ShikataJames McGillRob JustoPrem VenugopalPublished in: JIMD reports (2020)
Ornithine transcarbamylase (OTC) deficiency is an X-linked urea cycle disorder which-in severe form-results in rapid accumulation of ammonia and glutamine with subsequent irreversible brain injury. We present a case of severe left ventricular dysfunction with hyperammonemic crisis caused by OTC deficiency which was managed with veno-arterial extracorporeal membrane oxygenation support combined with continuous renal replacement therapy. Aggressive treatment led to normalization of ammonia and full left ventricular recovery.
Keyphrases
- extracorporeal membrane oxygenation
- left ventricular
- brain injury
- acute respiratory distress syndrome
- respiratory failure
- acute kidney injury
- subarachnoid hemorrhage
- early onset
- replacement therapy
- heart failure
- acute myocardial infarction
- oxidative stress
- hypertrophic cardiomyopathy
- cardiac resynchronization therapy
- mechanical ventilation
- room temperature
- aortic stenosis
- left atrial
- drug induced
- anaerobic digestion
- cerebral ischemia
- coronary artery disease
- acute coronary syndrome
- percutaneous coronary intervention
- sensitive detection